CT Protocol for Choledocholithiasis, Cholangitis, and Cholecystitis
For evaluating choledocholithiasis, cholangitis, and cholecystitis, perform CT abdomen WITH intravenous contrast only—do not add a noncontrast phase unless there is known chronic disease or neoplasia. 1
Rationale for Contrast-Enhanced CT Only
The ACR Appropriateness Criteria explicitly state that "little additional information is gained by the routine addition of a noncontrast phase to a contrast-enhanced phase in this clinical setting, without prior chronic disease or neoplasia." 1 This is critical because:
- Adjacent liver parenchymal hyperemia is one of the earliest and most useful findings in acute cholecystitis and can only be detected with IV contrast 1
- Gallbladder wall enhancement patterns distinguish acute from chronic cholecystitis and identify complications like gangrene, but require IV contrast 1, 2
- Pericholecystic inflammatory changes are better characterized with contrast enhancement
What Noncontrast CT Misses
While noncontrast CT can detect some features (gallbladder wall thickening, pericholecystic inflammation, gas formation, hemorrhage), it cannot detect critical findings including:
- Wall enhancement abnormalities
- Adjacent liver hyperemia (an early sign)
- Mural devascularization indicating gangrene 1, 2
Performance Characteristics
For cholecystitis: CT with IV contrast has approximately 90% negative predictive value and effectively identifies complications including gangrene, perforation, gas formation, and intraluminal hemorrhage 1
For choledocholithiasis: CT sensitivity is only ~75% for detecting stones (many are non-calcified), but contrast-enhanced CT is 74-96% sensitive and 90-94% specific for detecting biliary obstruction itself 3. Recent data shows bile duct attenuation measured on contrast-enhanced CT can help differentiate choledocholithiasis from malignant obstruction 4
For cholangitis: Contrast-enhanced CT identifies the level and cause of biliary obstruction plus complications like abscess formation 3
Important Caveats
- CT is not first-line imaging—ultrasound should be performed first 1
- MRCP is superior to CT for detecting choledocholithiasis (85-100% sensitivity vs. 75% for CT) and should be considered when biliary stone disease is the primary concern 1
- Noncontrast CT has very limited value in suspected biliary disease 1
- CT is typically performed after ultrasound is negative or equivocal to clarify findings or identify complications 1
When to Add Noncontrast Phase
Only add a noncontrast phase if:
- Patient has known chronic liver disease
- Known or suspected neoplasia
- Specific concern for hemorrhage that needs characterization 1
The standard protocol is single-phase contrast-enhanced CT, as the morphology of stones and masses on post-contrast imaging alone is typically sufficient for diagnosis without needing to prove enhancement or lack thereof 3.